Company

PROTALEX INC (0001099215)

Standardized SEC financial data for PROTALEX INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001099215 · Services-Commercial Physical & Biological Research.

Return on equity

239.8%

Free cash flow

-$3.4M

Debt / equity

0.00×

Current ratio

1.00×

Ratios for fiscal year 2018, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018
Revenue	$0	$0	$0
R&D expense	$3.1M	$2.4M	$2.3M
SG&A expense	$5.2M	$754K	$1.5M
Operating income	-$9.0M	-$4.0M	-$4.4M
EBITDA	-$9.0M	-$4.0M	-$4.4M
Interest expense	$434K	$558K

Standardized from PROTALEX INC's SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2016	FY2017	FY2018
Cash & equivalents	$444K	$487K	$555K
Total current assets	$500K	$595K	$630K
Total assets	$503K	$597K	$631K
Total current liabilities	$607K	$547K	$629K
Total liabilities	$17.9M	$22.3M

Cash flow

USD	FY2016	FY2017	FY2018
Operating cash flow	-$4.3M	-$3.9M	-$3.4M
Investing cash flow	$0	$0	$0
Financing cash flow	$3.8M	$4.0M	$3.4M
Dividends paid	$0	$0	$0

Get 0001099215 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001099215/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001099215/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001099215 filings on SEC EDGAR →